Besponsa
Besponsa Approved for Pediatric Patients With Acute Lymphoblastic Leukemia
The FDA approved inotuzumab ozogamicin (Besponsa, Pfizer) for pediatric patients aged 1 year and older with ...
MARCH 7, 2024
Besponsa Approved for Adults With Relapsed/Refractory ALL
The FDA has approved inotuzumab ozogamicin (Besponsa, Pfizer) for the treatment of adults with relapsed or ...
AUGUST 22, 2017
Load more